Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rofecoxib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rofecoxib 12.5mg tablets
1001010AFAAACAC
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 12.5mg/5ml oral suspension sugar free
1001010AFAAAAAA
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 25mg tablets
1001010AFAAADAD
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 25mg/5ml oral suspension sugar free
1001010AFAAABAB
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Rofecoxib 50mg tablets
1001010AFAAAEAE
|
Rofecoxib | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Vioxx 12.5mg tablets
1001010AFBBACAC
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Vioxx 12.5mg/5ml oral suspension
1001010AFBBAAAA
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Vioxx 25mg tablets
1001010AFBBADAD
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Vioxx 25mg/5ml oral suspension
1001010AFBBABAB
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
VioxxAcute 25mg tablets
1001010AFBBAEAD
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
|
VioxxAcute 50mg tablets
1001010AFBBAFAE
|
Vioxx | Rofecoxib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.